Tetrahydroisoquinolines. I. 1-Alkyl-6,7-dihydroxy-1,2,3,4-tetrahydroisoquinolines<sup>1</sup>
作者:P. N. Craig、F. P. Nabenhauer、P. M. Williams、E. Macko、J. Toner
DOI:10.1021/ja01125a051
日期:1952.3
Nouveaux dérivés de l'acide boronique, leur procédé de préparation et les compositions pharmaceutiques qui les contiennent
申请人:ADIR ET COMPAGNIE
公开号:EP0792883B1
公开(公告)日:2000-12-20
PHARMACOLOGICAL AGENTS FOR TREATING OCULAR DISEASES
申请人:CALASIA PHARMACEUTICALS, INC.
公开号:US20210154213A1
公开(公告)日:2021-05-27
Methods of treating presbyopia or cataract in a subject in need thereof are provided. The methods require administering to the subject an effective amount of a composition comprising a compound that inhibits the formation of high molecular weight aggregates of human α-A-crystallin. Compositions containing certain compounds are believed to be also effective in the treatment of transthyretin (TTR)-associated amyloidosis and Parkinson's disease.
Mondon,A. et al., Justus Liebigs Annalen der Chemie, 1963, vol. 667, p. 126 - 140
作者:Mondon,A. et al.
DOI:——
日期:——
PAPAVERINE ANALOGS. IV. 1-CYCLOALIPHATIC-6,7-DIMETHOXYISOQUINOLINES